# Lantern Pharma Inc.: filings

LTRN · Nasdaq · CIK 1763950 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ltrn.md) · [Financials](/companies/ltrn/financials.md) · [Filings](/companies/ltrn/filings.md) · [Insiders](/companies/ltrn/insiders.md)

## Reports and events: 106 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 65, 8-K 57, 10-Q 19, 3 14, 144 13, CORRESP 10, UPLOAD 7, 10-K 6, DEF 14A 6, EFFECT 5, 424B5 4, ARS 4, SCHEDULE 13D/A 4, D 3, S-1 3, S-1/A 3, SC 13D 3, SC 13D/A 3, SC 13G 3, 10-K/A 2, 424B4 2, DEFA14A 2, DRS 2, DRSLTR 2, FWP 2, PRE 14A 2, S-1MEF 2, S-3 2, SCHEDULE 13G 2, SCHEDULE 13G/A 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, S-8 1, SC 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:15 ET | [DEF 14A](/filings/0001493152-26-047586.md) | Proxy statement, period 2026-10-19 | 0001493152-26-047586 |
| 2026-10-01 | 20:01 ET | [8-K](/filings/0001493152-26-045344.md) | 3.01 Delisting notice | 0001493152-26-045344 |
| 2026-09-30 | 20:05 ET | [8-K](/filings/0001493152-26-045100.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-045100 |
| 2026-09-24 | 00:41 ET | [8-K](/filings/0001493152-26-044007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-044007 |
| 2026-09-23 | 11:45 ET | [8-K](/filings/0001493152-26-043808.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043808 |
| 2026-08-14 | 11:35 ET | [8-K](/filings/0001493152-26-037979.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037979 |
| 2026-08-14 | 11:30 ET | [10-Q](/filings/0001493152-26-037971.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037971 |
| 2026-08-03 | 21:24 ET | [8-K](/filings/0001493152-26-035864.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035864 |
| 2026-06-12 | 20:30 ET | [S-1](/filings/0001493152-26-028460.md) | Registration statement | 0001493152-26-028460 |
| 2026-06-02 | 23:40 ET | [8-K](/filings/0001493152-26-026696.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-026696 |
| 2026-05-15 | 20:20 ET | [SCHEDULE 13D/A](/filings/0001813314-26-000008.md) | Ownership report, active investor, amended | 0001813314-26-000008 |
| 2026-05-15 | 20:07 ET | [8-K](/filings/0001493152-26-023758.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023758 |
| 2026-05-15 | 20:05 ET | [10-Q](/filings/0001493152-26-023740.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023740 |
| 2026-05-14 | 21:26 ET | [8-K](/filings/0001493152-26-023200.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-023200 |
| 2026-04-30 | 10:05 ET | [10-K/A](/filings/0001493152-26-019713.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-019713 |
| 2026-04-16 | 19:48 ET | [SCHEDULE 13D/A](/filings/0001813314-26-000005.md) | Ownership report, active investor, amended | 0001813314-26-000005 |
| 2026-04-10 | 12:00 ET | [8-K](/filings/0001493152-26-016047.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-016047 |
| 2026-03-30 | 21:36 ET | [10-K](/filings/0001493152-26-013612.md) | Annual report, period 2025-12-31 | 0001493152-26-013612 |
| 2026-03-30 | 21:35 ET | [8-K](/filings/0001493152-26-013608.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013608 |
| 2026-02-23 | 21:37 ET | [SCHEDULE 13D/A](/filings/0001813314-26-000002.md) | Ownership report, active investor, amended | 0001813314-26-000002 |
| 2026-01-23 | 12:31 ET | [8-K](/filings/0001493152-26-003314.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-003314 |
| 2025-11-13 | 13:30 ET | [8-K](/filings/0001493152-25-022134.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022134 |
| 2025-11-12 | 21:17 ET | [10-Q](/filings/0001493152-25-021927.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021927 |
| 2025-09-23 | 20:45 ET | [8-K](/filings/0001493152-25-014652.md) | 5.07 Shareholder vote results | 0001493152-25-014652 |
| 2025-08-13 | 20:15 ET | [8-K](/filings/0001641172-25-023489.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023489 |
| 2025-08-13 | 20:06 ET | [10-Q](/filings/0001641172-25-023471.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023471 |
| 2025-08-08 | 21:17 ET | [DEF 14A](/filings/0001641172-25-022820.md) | Proxy statement, period 2025-08-08 | 0001641172-25-022820 |
| 2025-07-29 | 21:05 ET | [8-K](/filings/0001641172-25-021407.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-021407 |
| 2025-07-03 | 20:10 ET | [8-K](/filings/0001641172-25-017810.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-017810 |
| 2025-06-13 | 23:43 ET | [SCHEDULE 13D/A](/filings/0001104659-25-059524.md) | Ownership report, active investor, amended | 0001104659-25-059524 |
| 2025-05-15 | 12:35 ET | [10-Q](/filings/0001641172-25-010547.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010547 |
| 2025-05-15 | 12:30 ET | [8-K](/filings/0001641172-25-010541.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010541 |
| 2025-04-30 | 00:56 ET | [10-K/A](/filings/0001641172-25-006728.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-006728 |
| 2025-03-27 | 20:05 ET | [10-K](/filings/0001641172-25-000926.md) | Annual report, period 2024-12-31 | 0001641172-25-000926 |
| 2025-03-27 | 20:03 ET | [8-K](/filings/0001641172-25-000917.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000917 |
| 2025-01-10 | 21:05 ET | [8-K](/filings/0001493152-25-001685.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-001685 |
| 2024-11-08 | 02:09 ET | [8-K](/filings/0001493152-24-044124.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044124 |
| 2024-11-07 | 21:07 ET | [10-Q](/filings/0001493152-24-044010.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044010 |
| 2024-11-07 | 21:05 ET | [8-K](/filings/0001493152-24-044006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044006 |
| 2024-08-08 | 20:07 ET | [10-Q](/filings/0001493152-24-030766.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030766 |
| 2024-08-08 | 20:07 ET | [8-K](/filings/0001493152-24-030764.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-030764 |
| 2024-06-17 | 20:15 ET | [8-K](/filings/0001493152-24-024110.md) | 5.07 Shareholder vote results | 0001493152-24-024110 |
| 2024-05-24 | 20:09 ET | [8-K](/filings/0001493152-24-021353.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-021353 |
| 2024-05-09 | 20:05 ET | [10-Q](/filings/0001493152-24-018422.md) | Quarterly report, period 2024-03-31 | 0001493152-24-018422 |
| 2024-05-09 | 20:05 ET | [8-K](/filings/0001493152-24-018426.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-018426 |
| 2024-04-29 | 11:30 ET | [DEF 14A](/filings/0001493152-24-016840.md) | Proxy statement, period 2024-04-29 | 0001493152-24-016840 |
| 2024-03-18 | 20:05 ET | [10-K](/filings/0001493152-24-010302.md) | Annual report, period 2023-12-31 | 0001493152-24-010302 |
| 2024-03-18 | 20:05 ET | [8-K](/filings/0001493152-24-010303.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-010303 |
| 2024-03-01 | 21:10 ET | [SC 13D/A](/filings/0001104659-24-029971.md) | Ownership report, active investor, amended | 0001104659-24-029971 |
| 2023-12-29 | 21:05 ET | [8-K](/filings/0001493152-23-046572.md) | 5.02 Departure or appointment of officers or directors | 0001493152-23-046572 |

Page 1 of 3. [Older](/companies/ltrn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.